Status:

ACTIVE_NOT_RECRUITING

HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) -Post-Traumatic Epilepsy (PTE)

Lead Sponsor:

Dartmouth-Hitchcock Medical Center

Collaborating Sponsors:

United States Department of Defense

Conditions:

Epilepsy, Traumatic

Brain Injuries, Traumatic

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to assess the ability of the home-based intervention, HOBSCOTCH-PTE, to improve the quality of life and cognitive function in Service Members, Veterans and civilians with ...

Detailed Description

The investigators hypothesis is that the home-based intervention (HOBSCOTCH-PTE) will improve quality of life and cognitive function in Service Members, Veterans and civilians with PTE. The integratio...

Eligibility Criteria

Inclusion

  • Inclusion Criteria/PTE Participants:
  • Age 18+
  • Diagnosis of post traumatic epilepsy, with controlled or uncontrolled seizures
  • Subjective memory complaints
  • No changes in antiepileptic and antidepressant medication regimen for 1 month, however brief discontinuation of antiepileptic medicine for inpatient video EEG evaluation is acceptable
  • Literate and proficient in English
  • Telephone access
  • Internet access
  • Exclusion Criteria/PTE Participants:
  • Subjects self-reporting a dementing illness or a mention of a dementing illness in their medical record
  • Severe mental disability or estimated IQ less than 70 per clinical judgement
  • Significant visual impairment precluding reading or writing
  • No reliable telephone or internet access
  • No diagnosis of epilepsy
  • Inclusion Criteria/Caregiver Participants
  • Age 18+
  • Caregivers to a patient with a confirmed diagnosis of PTE
  • Literate and proficient in English
  • Telephone access
  • Internet access
  • Exclusion Criteria/Caregiver Participants:
  • Significant visual impairment precluding reading or writing
  • No reliable telephone or internet access

Exclusion

    Key Trial Info

    Start Date :

    March 21 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    February 1 2026

    Estimated Enrollment :

    160 Patients enrolled

    Trial Details

    Trial ID

    NCT05235061

    Start Date

    March 21 2022

    End Date

    February 1 2026

    Last Update

    December 18 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, United States, 03756